Selling R&D Tax Credits: Liquidity for Innovation
For many early-stage companies and startups, R&D tax credits represent a vital source of non-dilutive capital, yet typically these credits are used to offset income tax liabilities that loss-making ventures do not yet have. To address this liquidity gap, specific jurisdictions—most notably states like New Jersey and Pennsylvania—have established Transferable Tax Credit programs. These programs allow qualified businesses to "sell" or transfer their unused R&D credits to other corporate taxpayers in exchange for immediate cash, often at a slight discount to the credit's face value. This mechanism transforms a deferred tax asset into immediate working capital, fueling further research and operational growth without the need for equity financing.
However, the marketplace for selling tax credits is rigorous and risk-averse; buyers require absolute certainty that the credits they are purchasing are legitimate and will withstand regulatory scrutiny. This is where the role of a specialist advisor becomes critical. The transfer process involves strict eligibility requirements, such as specific caps on the age of the credit or the size of the company, and often necessitates a comprehensive audit file. If a transferred credit is later disallowed by tax authorities, the financial and legal repercussions can sever buyer trust and result in significant penalties. Therefore, the "saleability" of a credit is directly proportional to the quality of its documentation and the defensibility of the underlying R&D claim.
Swanson Reed plays a pivotal role in this ecosystem by acting as an independent assurance provider, ensuring that R&D claims are meticulously substantiated before they ever reach the transfer market. By leveraging proprietary risk management tools like creditARMOR and their automated TaxTrex software, Swanson Reed validates the technical and financial data supporting the claim, effectively "wrapping" the credit in a layer of audit defense. While Swanson Reed remains independent and does not broker the sale themselves, their certification of a credit's validity significantly enhances its marketability, giving buyers the confidence to proceed and sellers the ability to maximize the cash value of their innovation assets.
Why Sell?
- 💰 Immediate Cash Flow for loss-making startups.
- 📉 Non-dilutive funding (no equity given up).
- 🚀 Reinvest capital directly into new R&D.
Market Value of $1.00 Credit
Buyers pay a premium for credits backed by reputable advisory firms like Swanson Reed.
The Transferability Landscape
Not all R&D credits are created equal. While Federal credits are generally non-transferable (with exceptions for specific M&A or Payroll Tax offsets), several states offer robust exchange programs.
Federal (Section 41)
Payroll Offset only (Startups)
State Programs
NJ, PA, MA, etc. (Sellable)
M&A Context
Transferred with ownership
Data reflects typical utilization strategies for a loss-making startup.
New Jersey (NOL)
Allows profitable tech/biotech companies to sell Net Operating Losses and R&D credits.
Pennsylvania
Credits can be sold or assigned. Highly competitive with strict caps.
Federal Payroll Offset
Not a sale, but a cash benefit. Offsets payroll tax up to $250k/year (increasing to $500k).
Swanson Reed's Advisory Role
Swanson Reed does not act as a broker. Instead, they provide the essential "Gold Standard" verification that makes a credit valuable to a buyer. A verified credit is a liquid asset.
CreditARMOR
A sophisticated audit defense and risk management platform. It ensures that if a buyer purchases your credit, the documentation stands up to IRS or State authority scrutiny.
TaxTrex (AI Analysis)
Advanced software that substantiates claims in real-time, reducing the risk of "estimation" errors that devalue credits during due diligence.
Transfer Calculation
Accurately calculating the "distributable" or "transferable" portion of the credit, separating non-qualifying expenses to protect the seller from future liability.
Value Preservation Funnel
Transfer Value Estimator
Buyers typically buy at 90-95 cents on the dollar.
Estimate only. Actual results depend on specific qualified research expenses (QRE) calculations.
Swanson Reed Tip: The "Market Discount Rate" improves significantly with better documentation. Audited/Reviewed claims trade closer to face value.
Monetizing R&D Tax Assets: The Strategic Landscape of Transferable Credits and Specialized Advisory
The monetization of Research and Development (R&D) tax credits operates within a bifurcated legislative framework, where the utilization of federal benefits is strictly distinct from the sale of state-level incentives. The federal R&D tax credit, governed by Internal Revenue Code Section 41, provides a crucial dollar-for-dollar reduction in federal tax liability for qualified domestic expenditures related to the design, development, or improvement of products, processes, or software.1 However, the Internal Revenue Service (IRS) explicitly prohibits the direct sale or transfer of this federal credit to a third-party taxpayer, maintaining that the incentive must primarily benefit the innovation of the generating company itself.2 For cash-constrained Qualified Small Businesses (QSBs), the only immediate federal avenue is applying the credit against payroll taxes, capped at $\$500,000$ annually.3 This restriction contrasts sharply with the state landscape, where jurisdictions such as New Jersey, Pennsylvania, and North Dakota have established marketplaces allowing companies with excess credit—often early-stage innovators with no current tax liability—to sell or transfer their state R&D credits to profitable corporate buyers.4 This option to sell transforms a deferred, uncertain tax asset, typically subject to a 20-year carryforward period that risks expiration before utilization 6, into immediate, non-dilutive liquidity, thereby extending the company’s financial runway and accelerating reinvestment into critical R&D initiatives.3
The strategic decision to sell state R&D credits is driven by the fundamental economic value of time and certainty. For technology and life sciences companies burning cash rapidly, accessing upfront capital to fund prototypes, experiments, and software platforms without incurring equity dilution represents a powerful financial tool.3 The ability to realize this immediate value, rather than waiting potentially decades for sufficient tax liability to accrue, justifies the discount credits are sold at in the secondary market. However, the viability of a credit sale hinges entirely on the quality and defensibility of the underlying claim. The corporate buyer assumes the audit risk associated with the original R&D activities, requiring stringent due diligence to ensure the expenditures meet the four-part test of qualified research under IRC §41 rules (often adopted by states).7 Consequently, the technical documentation—detailing qualified research expenditures (QREs) such as salaries, supplies, and contract research 1—must be prepared to the highest standard to withstand potential state tax authority scrutiny.8 This requirement necessitates the engagement of specialist tax advisory firms, whose primary function is to validate the claim’s compliance and maximize the recoverable face value, thereby securing a higher net return (lower discount rate) for the seller.
Swanson Reed plays a specialized and critical role in advising clients on the monetization of transferable credits by mitigating the substantial risks inherent in tax asset transactions. As one of the largest specialist R&D tax and innovation advisory firms, the company focuses exclusively on R&D tax credit preparation and audit services across all 50 states, servicing clients from start-ups to large corporations.9 Its advisory function extends into the commercial aspects of R&D and technology transfer 11, meaning the firm structures and validates the necessary documentation to render the R&D claim suitable for transferability. Crucially, Swanson Reed offers creditARMOR, a comprehensive risk transfer mechanism designed to mitigate both the financial and procedural liabilities associated with audits.13 By covering all associated defense expenses, including fees for CPAs, tax attorneys, and specialist consultants 9, creditARMOR provides assurance to the institutional credit buyer that the potential costs and volatility of a future audit have been ring-fenced. This de-risking of the asset stabilizes the transaction and increases the overall attractiveness of the transferable credit, ensuring the selling company maximizes its cash proceeds from the sale, thereby effectively leveraging state tax policy to fuel further innovation.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
